LLY

965.93

+4.72%↑

JNJ

187.89

+0.86%↑

UNH

321.52

-0.8%↓

NVS

127.05

+0.61%↑

ABT

125.76

-0.34%↓

LLY

965.93

+4.72%↑

JNJ

187.89

+0.86%↑

UNH

321.52

-0.8%↓

NVS

127.05

+0.61%↑

ABT

125.76

-0.34%↓

LLY

965.93

+4.72%↑

JNJ

187.89

+0.86%↑

UNH

321.52

-0.8%↓

NVS

127.05

+0.61%↑

ABT

125.76

-0.34%↓

LLY

965.93

+4.72%↑

JNJ

187.89

+0.86%↑

UNH

321.52

-0.8%↓

NVS

127.05

+0.61%↑

ABT

125.76

-0.34%↓

LLY

965.93

+4.72%↑

JNJ

187.89

+0.86%↑

UNH

321.52

-0.8%↓

NVS

127.05

+0.61%↑

ABT

125.76

-0.34%↓

Kodu・Aktsiate loetelu・Rockwell Medical Inc

Rockwell Medical Inc

Suletud

SektorTervishoid

1.05 6.06

Osta Müü

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

0.99

Max

1.05

Põhinäitajad
By Trading Economics
Aktsiakasum	-0.04
Töötajad	244

Soovitused
By TipRanks
Soovitused	Osta
12 kuu keskmine prognoos	+308.16% upside

Dividendid
By Dow Jones
Järgmine tulemuste avaldamine	12. nov 2025

Turustatistika
By TradingEconomics
Turukapital	4.4M 32M
Eelmine avamishind	-5.01
Eelmine sulgemishind	1.05

Rockwell Medical Inc Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

10. nov 2025, 22:17 UTC

Tulu

Commonwealth Bank Posts Flat 1Q Profit Despite Margin Pressure -- Update

10. nov 2025, 21:48 UTC

Tulu

Commonwealth Bank Posts Flat 1Q Profit Despite Margin Pressure

10. nov 2025, 23:44 UTC

Market Talk

Gold Edges Higher on Signs of Possible End to U.S. Govt Shutdown -- Market Talk

10. nov 2025, 23:43 UTC

Market Talk

Nikkei May Rise on Weaker Yen, Earnings Hopes -- Market Talk

10. nov 2025, 22:20 UTC

Omandamised, ülevõtmised, äriostud

Paramount Stock Climbs as Forecast Beats Estimates -- Barrons.com

10. nov 2025, 21:50 UTC

Market Talk

Tulu

Basic Materials Roundup: Market Talk

10. nov 2025, 21:50 UTC

Market Talk

Omandamised, ülevõtmised, äriostud

Health Care Roundup: Market Talk

10. nov 2025, 21:49 UTC

Omandamised, ülevõtmised, äriostud

Paramount Stock Climbs as Forecast Beats Estimates -- Barrons.com

10. nov 2025, 21:45 UTC

Tulu

PepsiCo and 3 Other Defensive Stocks to Ride Out a Vulnerable Market -- Barrons.com

10. nov 2025, 21:40 UTC

Tulu

Friedman Industries 2Q EPS 32c >FRD

10. nov 2025, 21:18 UTC

Tulu

Occidental Petroleum 3Q Adj EPS 64c >OXY

10. nov 2025, 21:17 UTC

Tulu

Occidental Petroleum 3Q EPS 65c >OXY

10. nov 2025, 21:17 UTC

Tulu

Occidental Petroleum 3Q Rev $6.72B >OXY

10. nov 2025, 21:16 UTC

Tulu

Occidental Petroleum 3Q EPS 65c >OXY

10. nov 2025, 21:16 UTC

Tulu

Occidental Petroleum 3Q Adj EPS 64c >OXY

10. nov 2025, 20:30 UTC

Market Talk

Expected End to U.S. Government Shutdown Helps Lift Crude -- Market Talk

10. nov 2025, 20:24 UTC

Market Talk

Hopes For New Government Data Lift Gold -- Market Talk

10. nov 2025, 20:08 UTC

Market Talk

U.S. Natural Gas Settles Higher As Colder Weather Arrives -- Market Talk

10. nov 2025, 19:49 UTC

Market Talk

Mexican Industrial Production Seen Soft in September -- Market Talk

10. nov 2025, 19:43 UTC

Tulu

Omandamised, ülevõtmised, äriostud

Paramount Earnings Come Amid Warner Bros Merger Reports -- Barrons.com

10. nov 2025, 19:16 UTC

Tulu

Charles Schwab's CEO Is Worried About Prediction Markets. What He Told Thousands of Financial Advisors. -- Barrons.com

10. nov 2025, 17:58 UTC

Omandamised, ülevõtmised, äriostud

Eli Lilly Stock on Pace for a New High. The Zepbound Maker Just Got a Big Upgrade. -- Barrons.com

10. nov 2025, 17:56 UTC

Market Talk

Oil Futures Edge Up in Rangebound Trade -- Market Talk

10. nov 2025, 17:32 UTC

Tulu

Barrick Looking to Reset Safety Culture Following Fatalities -- Interview

10. nov 2025, 17:30 UTC

Tulu

Barrick Continues Efforts to Free Workers Jailed in Mali -- Interview

10. nov 2025, 17:20 UTC

Market Talk

Tulu

Basic Materials Roundup: Market Talk

10. nov 2025, 17:20 UTC

Market Talk

Omandamised, ülevõtmised, äriostud

Health Care Roundup: Market Talk

10. nov 2025, 17:00 UTC

Tulu

Barrick Looks to Get Handle On North American Operations, Find Growth -- Interview

10. nov 2025, 17:00 UTC

Tulu

Barrick Expects Strong Cash Flows Ahead With Commodity Prices at Current Levels, CFO Says in Interview

10. nov 2025, 17:00 UTC

Tulu

Barrick Conducting Bottom-Up Review of Nevada Ops, Looking for Growth Opportunities

Võrdlus sarnastega

Hinnamuutus

Rockwell Medical Inc Prognoos

Hinnasiht

By TipRanks

308.16% tõus

12 kuu keskmine prognoos

Keskmine 4 USD 308.16%

Kõrge 5 USD

Madal 3 USD

Põhineb 2 Wall Streeti analüütiku instrumendi Rockwell Medical Inc 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Osta

2 ratings

Osta

Hoia

Müü

Põhineb 2 analüütiku instrumendi Rockwell Medical Inc aktsia reitingul - viimase 3 kuu andmed.

Finantsandmed

Ettevõttest Rockwell Medical Inc

Rockwell Medical, Inc., together with its subsidiaries, operates as a healthcare company that engages in the development, manufacture, commercialization, and distribution of various hemodialysis products for dialysis providers worldwide. Also, the company manufactures, sells, delivers, and distributes hemodialysis concentrates, such as CitraPure citric acid concentrate, Dri-Sate dry acid concentrate, RenalPure liquid acid concentrate, dry acid concentrate mixer, and RenalPure and SteriLyte powder bicarbonate concentrate; and ancillary products, including testing supplies, 5% acetic acid cleaning solution, 5% and 2% citric acid descaler, filtration salts, and other items used by hemodialysis providers. The company's hemodialysis concentrate products are used to sustain patient's life by removing toxins and balancing electrolytes in a dialysis patient's bloodstream. The company serves to hemodialysis clinics. Rockwell Medical, Inc. was formerly known as Rockwell Medical Technologies, Inc. and changed its name to Rockwell Medical, Inc. in June 2012. Rockwell Medical, Inc. was incorporated in 1996 and is headquartered in Wixom, Michigan.